STOCK TITAN

Axon (NASDAQ: AXON) director Adriane Brown receives 611-share equity award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Brown Adriane M reported acquisition or exercise transactions in this Form 4 filing.

AXON ENTERPRISE, INC. director Adriane M. Brown received an equity grant of 611 shares of Common Stock on May 29, 2026 as a compensation award. The shares are in the form of time-vested restricted stock units granted under the company’s Amended and Restated 2022 Stock Incentive Plan.

The award is scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders. Following this grant, Brown directly holds 8,437 shares of Axon common stock, indicating a relatively small, routine director equity award rather than an open-market transaction.

Positive

  • None.

Negative

  • None.
Insider Brown Adriane M
Role null
Type Security Shares Price Value
Grant/Award Common Stock 611 $0.00 --
Holdings After Transaction: Common Stock — 8,437 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares granted 611 shares Time-vested restricted stock units granted May 29, 2026
Share price for award $0.0000 per share Equity compensation grant, no cash paid
Shares owned after transaction 8,437 shares Director’s direct common stock holdings post-grant
restricted stock units financial
"Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Amended and Restated 2022 Stock Incentive Plan financial
"Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan."
Annual Meeting of Shareholders financial
"The award is scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders."
A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Brown Adriane M

(Last)(First)(Middle)
17800 NORTH 85TH STREET

(Street)
SCOTTSDALE ARIZONA 85255

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/29/2026A611(1)A$08,437D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The award is scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders.
Remarks:
/s/ Adrianne M. Brown, by Isaiah Fields, Attorney-in-Fact06/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did AXON director Adriane Brown report in this Form 4?

Adriane Brown reported receiving a grant of 611 shares of Axon common stock as time-vested restricted stock units. The award is compensation under Axon’s 2022 Stock Incentive Plan, not an open-market stock purchase or sale.

How many AXON shares did Adriane Brown acquire in this transaction?

Adriane Brown acquired 611 shares of Axon common stock through a restricted stock unit award. These units convert into shares upon vesting, increasing her direct holdings once the vesting conditions are met.

What is Adriane Brown’s AXON share ownership after this award?

After the reported grant, Adriane Brown directly holds 8,437 shares of Axon common stock. This figure reflects her position following the 611-share restricted stock unit award disclosed in the Form 4 filing.

When do Adriane Brown’s new AXON restricted stock units vest?

The restricted stock units are scheduled to vest in full on the earlier of the one-year anniversary of the May 29, 2026 grant date and the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders, subject to plan terms.

Was cash paid for the AXON shares granted to Adriane Brown?

No cash was paid for the shares; the per-share price is reported as 0.0000. The 611-share award represents equity compensation granted under Axon’s Amended and Restated 2022 Stock Incentive Plan rather than a market purchase.

Is this AXON Form 4 transaction a market buy or sell?

This transaction is a grant or award acquisition, not a market buy or sell. The Form 4 uses transaction code A, indicating a compensation-related award of 611 restricted stock units at no cash cost.